The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
The global Vaccines market was valued at US$ 45280 million in 2023 and is anticipated to reach US$ 66610 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
The major players in global Vaccines market include Merck, GSK, Sanofi, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market. Recombinant Vaccines is the main type, with a share about 35%. Rabies vaccine, Influenza vaccine, HPV vaccine are main applications, which hold a share about 35%.
This report aims to provide a comprehensive presentation of the global market for Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccines.
Report Scope
The Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- GSK
- Sanofi
- Merck
- Pfizer
- Novartis(GSK)
- CSL
- MedImmune LLC
- J&J(Crucell)
- China National Biotec
- Tiantan
- Hualan
- Kangtai
- Hissen
- Jintan
Segment by Type
- Recombinant Vaccines
- Viral Vaccines
- Polysaccharide Vaccines
- Others
Segment by Application
- Rabies vaccine
- Influenza vaccine
- HPV vaccine
- Hepatitis B
- Hepatitis A
- Leprosy vaccine
- Polio vaccine
- JE vaccine
- Others
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Vaccines Market Overview
1.1 Product Overview and Scope of Vaccines
1.2 Vaccines Segment by Type
1.2.1 Global Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Recombinant Vaccines
1.2.3 Viral Vaccines
1.2.4 Polysaccharide Vaccines
1.2.5 Others
1.3 Vaccines Segment by Application
1.3.1 Global Vaccines Market Value by Application: (2024-2030)
1.3.2 Rabies vaccine
1.3.3 Influenza vaccine
1.3.4 HPV vaccine
1.3.5 Hepatitis B
1.3.6 Hepatitis A
1.3.7 Leprosy vaccine
1.3.8 Polio vaccine
1.3.9 JE vaccine
1.3.10 Others
1.4 Global Vaccines Market Size Estimates and Forecasts
1.4.1 Global Vaccines Revenue 2019-2030
1.4.2 Global Vaccines Sales 2019-2030
1.4.3 Global Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Vaccines Market Competition by Manufacturers
2.1 Global Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vaccines, Product Type & Application
2.7 Vaccines Market Competitive Situation and Trends
2.7.1 Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Vaccines Players Market Share by Revenue
2.7.3 Global Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vaccines Retrospective Market Scenario by Region
3.1 Global Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Vaccines Global Vaccines Sales by Region: 2019-2030
3.2.1 Global Vaccines Sales by Region: 2019-2024
3.2.2 Global Vaccines Sales by Region: 2025-2030
3.3 Global Vaccines Global Vaccines Revenue by Region: 2019-2030
3.3.1 Global Vaccines Revenue by Region: 2019-2024
3.3.2 Global Vaccines Revenue by Region: 2025-2030
3.4 North America Vaccines Market Facts & Figures by Country
3.4.1 North America Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Vaccines Sales by Country (2019-2030)
3.4.3 North America Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Vaccines Market Facts & Figures by Country
3.5.1 Europe Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Vaccines Sales by Country (2019-2030)
3.5.3 Europe Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Vaccines Market Facts & Figures by Country
3.7.1 Latin America Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vaccines Sales by Type (2019-2030)
4.1.1 Global Vaccines Sales by Type (2019-2024)
4.1.2 Global Vaccines Sales by Type (2025-2030)
4.1.3 Global Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Vaccines Revenue by Type (2019-2030)
4.2.1 Global Vaccines Revenue by Type (2019-2024)
4.2.2 Global Vaccines Revenue by Type (2025-2030)
4.2.3 Global Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Vaccines Sales by Application (2019-2030)
5.1.1 Global Vaccines Sales by Application (2019-2024)
5.1.2 Global Vaccines Sales by Application (2025-2030)
5.1.3 Global Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Vaccines Revenue by Application (2019-2030)
5.2.1 Global Vaccines Revenue by Application (2019-2024)
5.2.2 Global Vaccines Revenue by Application (2025-2030)
5.2.3 Global Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Vaccines Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Vaccines Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Vaccines Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Vaccines Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Novartis(GSK)
6.5.1 Novartis(GSK) Corporation Information
6.5.2 Novartis(GSK) Description and Business Overview
6.5.3 Novartis(GSK) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Novartis(GSK) Vaccines Product Portfolio
6.5.5 Novartis(GSK) Recent Developments/Updates
6.6 CSL
6.6.1 CSL Corporation Information
6.6.2 CSL Description and Business Overview
6.6.3 CSL Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 CSL Vaccines Product Portfolio
6.6.5 CSL Recent Developments/Updates
6.7 MedImmune LLC
6.6.1 MedImmune LLC Corporation Information
6.6.2 MedImmune LLC Description and Business Overview
6.6.3 MedImmune LLC Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 MedImmune LLC Vaccines Product Portfolio
6.7.5 MedImmune LLC Recent Developments/Updates
6.8 J&J(Crucell)
6.8.1 J&J(Crucell) Corporation Information
6.8.2 J&J(Crucell) Description and Business Overview
6.8.3 J&J(Crucell) Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 J&J(Crucell) Vaccines Product Portfolio
6.8.5 J&J(Crucell) Recent Developments/Updates
6.9 China National Biotec
6.9.1 China National Biotec Corporation Information
6.9.2 China National Biotec Description and Business Overview
6.9.3 China National Biotec Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 China National Biotec Vaccines Product Portfolio
6.9.5 China National Biotec Recent Developments/Updates
6.10 Tiantan
6.10.1 Tiantan Corporation Information
6.10.2 Tiantan Description and Business Overview
6.10.3 Tiantan Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Tiantan Vaccines Product Portfolio
6.10.5 Tiantan Recent Developments/Updates
6.11 Hualan
6.11.1 Hualan Corporation Information
6.11.2 Hualan Vaccines Description and Business Overview
6.11.3 Hualan Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hualan Vaccines Product Portfolio
6.11.5 Hualan Recent Developments/Updates
6.12 Kangtai
6.12.1 Kangtai Corporation Information
6.12.2 Kangtai Vaccines Description and Business Overview
6.12.3 Kangtai Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Kangtai Vaccines Product Portfolio
6.12.5 Kangtai Recent Developments/Updates
6.13 Hissen
6.13.1 Hissen Corporation Information
6.13.2 Hissen Vaccines Description and Business Overview
6.13.3 Hissen Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Hissen Vaccines Product Portfolio
6.13.5 Hissen Recent Developments/Updates
6.14 Jintan
6.14.1 Jintan Corporation Information
6.14.2 Jintan Vaccines Description and Business Overview
6.14.3 Jintan Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Jintan Vaccines Product Portfolio
6.14.5 Jintan Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vaccines Industry Chain Analysis
7.2 Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vaccines Production Mode & Process
7.4 Vaccines Sales and Marketing
7.4.1 Vaccines Sales Channels
7.4.2 Vaccines Distributors
7.5 Vaccines Customers
8 Vaccines Market Dynamics
8.1 Vaccines Industry Trends
8.2 Vaccines Market Drivers
8.3 Vaccines Market Challenges
8.4 Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
